Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with β-Thalassemia Major

BACKGROUND AND AIMS: β-thalassemia major patients are susceptible to Hepatitis C Virus (HCV) infection owing to life-long dependency for blood-transfusion. Moreover, this patient population is at risk of progression of liver fibrosis or development of cirrhosis as a consequence of both iron overload...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Exp Hepatol
Autores principales: Mehta, Rajiv, Kabrawala, Mayank, Nandwani, Subhash, Desai, Pankaj, Bhayani, Vishwa, Patel, Sanjay, Parekh, Viral
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5938522/
https://ncbi.nlm.nih.gov/pubmed/29743790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2017.06.002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares